IVUS vs Angiography Guidance for Diabetes Patients
IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus
Recruiting
N/A
Interventional Study
Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,332 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Other
Who this trial is looking for
This trial is looking for patients with diabetes who need a procedure to open blocked arteries. Participating involves receiving either an ultrasound or standard imaging to guide the procedure.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 80 years old
- I have been diagnosed with diabetes
- I need a procedure called PCI with a drug-eluting stent
- I have silent angina, stable angina, unstable angina, or a heart issue called Non-ST-elevation myocardial infarction
You may not be able to join if
- I am in cardiogenic shock
- I have had heart surgery called CABG
- My heart's pumping ability is low (ejection fraction < 30%)
- I am taking blood thinners
- I have severe kidney disease (eGFR < 20 ml/min/1.73m2)
- My platelet count is low (< 100,000 mm3)
- I cannot take the study medications or metal used in the study
- I expect to live less than a year
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intravascular ultrasound (IVUS) serves as a beneficial instrument during percutaneous coronary intervention (PCI) procedures, affording insight into lesion characteristics and stent implantation. The ULTIMATE trial recently evidenced that IVUS-guided Drug-Eluting Stent (DES) implantation notably ameliorated clinical outcomes in all-comers, especially in patients who underwent an optimal procedure …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age between 18 \~ 80 years old,
2. Confirmed diabetes mellitus
3. Indications for undergoing percutaneous coronary intervention using a drug-eluting stent (Invasive or quantitative fractional flow reserve (QFR or FFR) \<0.80)
4. Silent angina, stable angina, unstable angina, …
Contacts